21:42 ยท 12 November 2026

Oil Gains Nearly 2% Despite a Sharp Rise in US Inventories ๐Ÿ“ˆ

  • EIA crude oil inventories rose by 4.657 million barrels versus an expected decline of 1.483 million and a previous drop of 0.865 million barrels.

  • Gasoline inventories increased by 1.799 million barrels versus an expected decline of 0.35 million and a previous drop of 0.222 million barrels.

  • Distillate inventories rose by 4.071 million barrels versus an expected decline of 2.0 million and a previous drop of 3.565 million barrels.

  • Crude inventories at Cushing increased by 0.106 million barrels versus a 0.280 million-barrel build previously.

The EIA data were negative for the oil price outlook, as nearly all major inventory categories surprised with sizeable builds instead of the expected declines. The simultaneous increase in crude, gasoline and distillate inventories looks particularly weak and may point to softer end-demand or greater supply in the system than the market had anticipated. If the data are not offset by stronger export demand or renewed geopolitical risks, the report could increase downside pressure on prices, although the immediate market reaction does not point in that direction. Futures on Texas WTI (OIL.WTI) is gaining almost 1.5%, while Brent (OIL) is up around 2%, supported by renewed geopolitical uncertainty arount the US - Iran deal.

Source: XTB

13 November 2026, 10:45

Morning Wrap - Will the markets recover from the scandal involving Nvidia's ousted CEOโ“

12 November 2026, 23:08

Daily Summary: Oil Rebounds, EURUSD Falls Sharply ๐Ÿ—ฝ Wall Street Stabilizes After Nvidia Sell-Off

12 November 2026, 21:34

USDJPY Pulls Back After Reaching 160 ๐Ÿšฉ Is Tokyo Intervening in the Yen Again?

12 November 2026, 19:17

๐Ÿšฉ Gold loses almost 3%

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.